Myriad Genetics
American biotechnology company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Myriad Genetics?
Summarize this article for a 10 year old
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.
Company type | Public |
---|---|
Nasdaq: MYGN S&P 600 Component | |
Industry | Healthcare Molecular Diagnostics Biotechnology Precision Medicine |
Founded | Salt Lake City, Utah, United States (1991) |
Headquarters | Salt Lake City, Utah |
Key people | Paul J. Diaz, President and CEO Mark Skolnick, Co-Founder Peter Meldrum, Co-Founder Kevin Kimberlin, Co-Founder Jerry Lanchbury, CSO Walter Gilbert, Director and Vice Chair |
Revenue | $690.6 Million(2021)[1] |
Number of employees | 2,600[2] |
Website | www |